Jeffrey Allen Morris is > 10% Shareholder of PROVECTUS BIOPHARMACEUTICALS, INC.. Currently has a direct ownership of 4.26 Million shares of PVCT, which is worth approximately $553,807. The most recent transaction as insider was on Aug 12, 2024, when has been sold 264,314 shares (Series D-1 Convertible Preferred Stock) at a price of $2.86 per share, resulting in proceeds of $755,938. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.26M
0% 3M change
6.61% 12M change
Total Value Held $553,807

Jeffrey Allen Morris Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2024
BUY
Conversion of derivative security
$755,938 $2.86 p/Share
264,314 Added 5.84%
4,260,061 Series D-1 Convertible...
May 08 2023
BUY
Conversion of derivative security
$539,845 $2.86 p/Share
188,757 Added 4.51%
3,995,747 Series D-1 Convertible...
JAM

Jeffrey Allen Morris

> 10% Shareholder
Maryville, TN

Track Institutional and Insider Activities on PVCT

Follow PROVECTUS BIOPHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PVCT shares.

Notify only if

Insider Trading

Get notified when an Provectus Biopharmaceuticals, Inc. insider buys or sells PVCT shares.

Notify only if

News

Receive news related to PROVECTUS BIOPHARMACEUTICALS, INC.

Track Activities on PVCT